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This study was aimed to evaluate the hypoglycaemic and hypolipidemic effects of different doses of 
pumpkin (Cucurbita pepo L.) powder in male diabetic rats. A total of 35 rats were randomized into 5 
groups of 7 each as follows: Group 1: Normal control; Group 2: Diabetic control; Group 3: Diabetics 
administered with low doses of pumpkin powder (1 g/kg); Group 4: Diabetics administered with high 
doses of pumpkin powder (2 g/kg), and Group 5: Diabetics administered with glibenclamide (0.6 mg/kg), 
as positive control. The rats were made diabetic by alloxan (120 mg/kg body weight (BW)) injection and 
were treated for 4 weeks on a daily basis. Blood samples were collected following the experiment. 
Pancreatic specimens were also collected for histological analysis. Glucose, cholesterol, triglycerides, 
low density lipoprotein (LDL) and C-reactive protein (CRP) were significantly increased, while insulin 
was decreased in diabetic rats as compared to the normal control group (p < 0.05). Low dose pumpkin 
significantly decreased glucose, triglycerides, LDL and CRP as compared to diabetic group and high 
dose pumpkin decreased cholesterol (p < 0.05). Histological analysis also revealed a significant 
increase in the diameter and number of langerhans islets in treated group with pumpkin, which was 
consistent with the latter findings. Therefore, pumpkin might be beneficial in diabetic patients. 
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INTRODUCTION 
 
Diabetes mellitus is a chronic disorder of carbohydrate, 
lipid and protein metabolism manifested by elevated 
blood glucose level. This disease is caused by a defect in 
cellular uptake of glucose due to either reduced insulin 
secretion or cellular resistance to insulin (DeFronzo, 
1997; Hughs et al., 1984). Clinically, diabetes is an 
important risk factor for a range of diseases including 
nephropathy, retinopathy and neuropathy, and it is 
increasing in prevalence according to some estimates 
(Tripathi   and   Srivastava,    2006).    In    addition,   lipid 
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disorders and lipid per-oxidation together with diabetes 
play a crucial role in the development of cardiovascular 
disease (David et al., 2005; Roland et al., 2004). 
Although, insulin and hypoglycaemic drugs constitute the 
main treatment in diabetes, the use of nutritional methods 
and medicinal plants are increasing in some countries  
(Grover et al., 2002; Khan and Anderson, 2003). 
Pumpkins (genus; Cucurbita) belong to the family of 
Cucurbitaceae. They are classified as Cucurbita pepo, 
Cucurbita moschata, Cucurbita maxima and Cucurbita 
mixta according to the texture and shape of their stems. 
This family contains chemicals, including tetra cyclic 
triterpens, saponins, proteins, fibers, polysaccharides and 
minerals    (iron,     zinc,     manganese,     copper,     etc) 
 
 
 
 
(Bombardelli and Morazzoni, 1997; Lazos, 1986). Pectin, 
a major component of plant cell walls, it is a water-soluble 
fiber found abundantly in pumpkin plants (Fissore et al., 
2009). The seeds of this plant, which have been im-
plicated in providing many health benefits, are rich 
natural source of fatty acids (including linoleic acid, oleic 
acid, palmitic acid and stearic acid), phenolic compounds 
(Applequist et al., 2006; Xanthopoulou et al., 2009) and 
also, antioxidant vitamins, such as carotenoids and 
tocopherol (Stevenson et al., 2007). So far, several phar-
macological properties have been reported for different 
species of pumpkin including anti-oxidant, lipid-lowering, 
hepatoprotective (Makni et al., 2008), anti-carcinogenic 
(Hong, 2005), anti-microbial (Park et al., 2010) and anti-
diabetic properties (Caili et al., 2006; Xia and Wang, 
2006). Therefore, the aim of this study was to investigate 
the effects of various doses of C. pepo on elevated blood 
glucose and lipid levels and the histological changes of 
pancreatic tissue in type 1 diabetes in male rats. 
 
  
MATERIALS AND METHODS 
 
Preparation and standardization of pumpkin powder 
 
The fruit pumpkin (C. pepo L.) was cultivated in a farm in Isfahan in 
April 2008. The genus and species was confirmed by technicians of 
the Botany Department of Isfahan University and a voucher 
specimen (No.1400) was kept in the herbarium of the Faculty of 
Pharmacy, Isfahan University of Medical Sciences. The fruits were 
cut and dried in well-ventilated stores under standard conditions 
away from sunlight, moisture and microbial contamination .The 
plants were then powdered using electric grinders. 
The pumpkin has been analyzed for the presence of 
phytochemicals (Mukesh et al., 2010). However, because the 
proportion of each phytochemical in plants of same species vary in 
different regions, we standardized the pumpkin by measuring the 
amounts of its phenolic and polysaccharide compounds as well as 
antioxidant activity.  
 
 
Measurement of total phenolic compounds 
 
The amount of total phenolic compounds in pumpkin was deter-
mined colorimetrically using the Folin-Ciocalteu reagent, by Francis 
(1982) method. In brief, 5 ml of pumpkin extract or gallic acid 
(standard phenolic compound) was mixed with Folin-Ciocalteu 
reagent (1:10 diluted with distilled water) and aqueous Na2CO3 (4 
ml, 1 M). The mixtures were allowed to stand for 15 min, and the 
total phenols were determined by colorimetry at 765 nm. A standard 
curve was prepared using 0, 50, 100, 150, 200 and 250 mg/L 
solutions of gallic acid in methanol:water (50:50, v/v). Total phenol 
values were expressed in terms of gallic acid equivalent (mg/g). 
The experiment was repeated in triplicate. 
 
 
Measurement of polysaccharides 
 
The Beck and Bibby (1961) anthrone technique was employed for 
polysaccharide determination with some modifications. Briefly,  4  or  
5 ml of the diluted samples of pumpkin extract was added to 0.5 ml 
of the 2% anthrone-ethyl acetate reagent in suitable test tubes. 5 ml 
of 96.7% sulfuric acid were then carefully layered into each tube. 
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The contents of the tube were then thoroughly mixed by more rapid 
swirling to redissolve the anthrone in the sulfuric acid and it was left 
in the boiling water for a total of 10 min. They were then transferred 
to an ice bath for 5 min. The samples were transferred to optical 
tubes and read in a colorimeter using a 630 3-(4,5-dimethythiazol-. 
2-yl)-2,5-diphenyl tetrazolium bromide (MTT) filter. Glucose with 
dilutions of 0 to 100 µl was used to prepare standard curve. Each 
sample was read three times, the 100 per cent transmittance being 
checked and adjusted if necessary with the distilled water-reagent-
sulfuric acid blank between each reading. The means of the three 
readings were used to derive optical density values, which were 
substituted in the regression equation to give the carbohydrate 
concentrations. The mean of the three aliquots was taken as the 
final carbohydrate value. 
 
 
Evaluation of antioxidant activity 
 
Antioxidant activity of the extract samples was determined using the 
ferric thiocyanate method (Masude et al., 1992). In this method, 500 
µg of each sample was dissolved in ethanol and was added to a 
reaction mixture containing 2.88 ml of 2.5% linoleic acid and 9 ml of 
40 mM phosphate buffer in a vial. The vials were incubated at 40°C 
for 96 h. During incubation (every 12 h), 0.1 ml of each vial was 
diluted with 9.7 ml of 75% ethanol, 0.1 ml of ammonium thiocyanate 
and 0.1 ml of FeCl2. The absorbance of samples was measured at 
500 nm, and the percentage inhibition (the capacity to inhibit the 
peroxide formation in linoleic acid) was determined using the 
following equation:  
 
Percentage of inhibition = (1-[absorbance of sample/absorbance of 
control]) × 100 
 
A high inhibition percentage indicates a high antioxidant activity. 
Ethanol within the sample and without reagents was used as the 
negative control. 
 
 
Laboratory animals 
 
In the present experiment, white male Wistar rats (Ratus norvegicus 
allivias) in the range of 180 to 220 g body weight were provided by 
Ahvaz Medical University. The animals were kept under standard 
conditions in Esfahan University’s animal house and had free 
access to water and food. In order for the animals to adapt to the 
new environment all experiments were carried out 2 weeks after 
their accommodation. All of the animal experimental procedures 
validated by the local ethical committee of the Shahrekord 
University of Medical Sciences (No: 1389/209). 
 
 
Induction of diabetes 
 
Type 1 diabetes was induced using intraperitoneal injection of 
alloxan monohydrate (120 mg/kg) (Sigma, Germany) which was 
dissolved in normal saline immediately before usage (Venkatesh et 
al., 2010; Madhavan et al., 2008). Diabetes was verified in the 
animal by measuring fasting blood glucose 3 days following alloxan 
injection (Ragavan and Krishnakumari, 2006; Rajagopal and 
Sasikala, 2008). Rats with glucose levels over 130 mg/dl were 
considered diabetic (Sharma et al., 2010; Quanhong et al., 2005). 
 
 
Categorization 
 
A total of 35 rats were randomized into 5 groups of 7 each: group 1: 
normal control; Group 2: Diabetic control; Group 3: Diabetic rats 
treated with pumpkin powder (1 g/kg) by gavage; Group 4: Diabetic  
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rats treated with pumpkin powder (2 g/kg) by gavage, group 5: 
diabetic rats treated with reference drug, glibenclamide (0.6 
mg/kg/day) for 4 weeks, as positive control. 
 
 
Blood sampling and biochemical tests 
 
Following the 4-week period, blood samples were collected and the 
levels of glucose, insulin, plasma lipid and lipoprotein and CRP 
were measured. The animals were deprived of food for 16 h before 
blood sampling (Ragavan and Krishnakumari, 2006; Asgary et al., 
2008). Blood samples were kept at room temperature for 40 min 
and then subjected to centrifugation at 3000 rpm for 15 min and 
was utilized for biochemical studies (Quanhong et al., 2005). 
The concentration of cholesterol, triglyceride, low density 
lipoprotein (LDL), high density lipoprotein (HDL) and C-reactive 
protein (CRP) was measured using commercially available kit 
obtained from Pars Azmoon (Iran) which utilized the colorimetric 
method (Rifai et al., 1999; Thompson et al., 1992). Plasma glucose 
levels were estimated by an enzymatic glucose oxidase-peroxidase 
(GOD-POD) method using commercially available kit obtained from 
BioSystems (Iran) (Trinder, 1969). Plasma insulin was determined 
using Monobind kit and Enzyme Linked Immunosorbant Assay 
(ELISA) method (Turkington et al., 1982).  
 
 
Histological examinations 
 
At the end of the experiment the rats were euthanized and the 
pancreas was removed. The specimens were washed with normal 
saline and were fixed in 10% formalin. The tissues were then 
dehydrated and cut into 5 micron sections and were stained with 
hematoxylin and eosin. Prepared slides were examined for mean 
diameter and number of Langerhans islets under the light 
microscope (Asgary et al., 2008). 
 
 
Statistical analysis of data 
 
Analysis of data was performed using the SPSS statistical software, 
version 11, with one way ANOVA. The differences among means 
were tested for significance using least significant difference (LSD) 
post hoc test. The criterion for statistical significance was p < 0.05. 
Data are presented as means with ±SE.  
 
 
RESULTS 
 
Polysaccharides, phenolic compounds and 
antioxidant activity 
 
The amount of polysaccharides in dried pumpkin was 
estimated to be 43.65 mg/g equivalent to glucose and the 
amount of phenolic compounds was 12 mg/g equivalent 
to gallic acid. The antioxidant activity (the percentage 
inhibition or the capacity to inhibit the peroxide formation 
in linoleic acid) of pumpkin was estimated to be 14%. 
 
 
Comparison of groups with respect to glucose and 
insulin levels 
 
Serum glucose levels were found to be significantly 
higher in diabetic control group  as  compared  to  normal  
 
 
 
 
control group. Similar to glibenclamide, consumption of 1 
and 2 g/kg pumpkin powder significantly reduced glucose 
levels in diabetic rats as compared to diabetic control 
group (p < 0.05) (Table 1). Insulin levels were shown to 
be significantly lower in diabetic control group as com-
pared to normal control group. Pumpkin powder (low and 
high doses) consumption increased this value, although 
not significantly, whereas glibenclamide consumption 
significantly increased insulin levels when compared with 
diabetic control group (p < 0.05) (Table 1). 
 
 
Comparison of groups with respect to cholesterol 
and triglyceride levels 
 
It is apparent from the results that cholesterol and 
triglyceride levels significantly increased in diabetic con-
trol group as compared to the normal control group. 
Administration of high dose pumpkin (2 g/kg) to diabetic 
rats significantly reduced cholesterol levels as compared 
to diabetic control group (p < 0.05) (Table 1). 
Similar to glibenclamide consumption of both high and 
low dose pumpkin significantly reduced triglyceride levels 
as compared to diabetic control group (p < 0.05) (Table 
1). 
 
 
Comparison of groups with respect to lipoprotein 
levels 
 
LDL levels were found to be significantly higher in 
diabetic control group as compared to normal control 
group.  
Consumption of pumpkin powder in diabetic rats lead to 
a significant decrease in blood LDL. Table 1 illustrates 
that glibenclamide was not as effective as pumpkin in 
reducing blood LDL levels and therefore no significant 
difference was observed between this group and the 
diabetic control group. 
It is evident from the results that reduction of HDL 
levels in diabetic control group as compared to the nor-
mal control group was not significant but administration of 
glibenclamide to diabetic rats significantly increased this 
factor as compared to diabetic the control group. 
In this regard, there was a significant difference 
between low and high dose pumpkin, where low-dose 
pumpkin (1 g/kg) proved to be more effective in increa-
sing this factor in diabetic rats (p < 0.05) (Table 1). 
 
 
Comparison of groups with respect to CRP levels 
 
Results indicate that this factor increases in diabetic 
control group compared to the other groups and that 
administration of pumpkin powder (low and high doses) 
has significantly reduced it to the level seen in normal 
control group.  The  group  given  glibenclamide  was  not  
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Table 1. Effect of pumpkin powder on the level of biochemical factors in normal and diabetic rats. 
 
 
Normal 
control 
Diabetic control 
Pumpkin 
powder (1 g/kg) 
Pumpkin powder 
(2 g/kg) 
Glibenclamide 
(0.6 mg/kg) 
Glucose (mg/dl) 69.71 ± 6.21* 246 ± 30.33
†
 104.2 ± 10.79* 98.75 ± 25.96* 105.5 ± 8.61* 
Insulin (µU/ml) 2.06 ± 0.49* 1.04 ± 0.22
†
 1.84 ± 0.16 1.55 ± 0.06 2.12 ± 0.49* 
Triglycerides (mg/dl) 58.42 ± 9.73* 103.6 ± 22.89
†
 51.8 ± 4.46* 25.75 ± 6.9* 41.83 ± 8.24* 
Total cholesterol (mg/dl) 78.85 ± 4.1* 107.4 ± 5.51
†
 96.2 ± 8.96 68.5 ± 9.28* 94.83 ± 9.4 
LDL (mg/dl) 18.66 ± 1.05* 24.6 ± 1.12
†
 18 ± 2.46* 16 ±1.47* 22.66 ± 2.24 
HDL (mg/dl) 40.57 ± 1.6 39.8 ± 3.56 49.8 ± 3.33 37.75 ± 4.71
‡
 51.66 ± 4.2*
†
 
CRP (mg/dl) 39.71 ± 2.45* 52.4 ± 1.53
†
 40.8 ± 4.53* 39 ± 1.22* 50.33 ± 1.42
†
 
 
Values are given as mean ± S.E (n = 7). *Significance difference versus diabetic control (p < 0.05). 
†
Significance difference versus normal control 
(p < 0.05). 
‡
Significantly difference versus high dose and low dose of pumpkin powder (p < 0.05).  
 
 
 
Table 2. Effect of pumpkin powder on size and number of Langerhans islets in normal and diabetic rats. 
 
 
Normal 
control 
Diabetic 
control 
Pumpkin 
powder (1 g/kg) 
Pumpkin powder 
(2 g/kg) 
Glibenclamide 
(0.6 mg/kg) 
Size of islets (micron) 1.3 ± 0.14* 0.5 ± 0.02
†
 0.87 ± 0.07
†
 1.06 ± 0.21* 0.91 ± 0.12
†
 
Number of islets  6 ± 0.54* 2.6 ± 0.23
†
 4.6 ± 0.74* 4 ± 0.4
†
 4 ± 0.68
†
 
 
Values are given as mean ±S.E (n=7). *Significance difference versus diabetic control (p < 0.05). 
†
Significance difference versus 
normal control (p < 0.05). 
 
 
 
significantly different from diabetic control group in this 
regard (p < 0.05) (Table 1). 
 
 
Histological results 
 
Histomorphological analysis shows that the mean 
diameter and number of the Langerhans islets are dif-
ferent among experimental groups. The mean diameter 
and number of Langerhans islets (evaluated in 5 micron 
sections), were significantly reduced in diabetic control 
group as compared to the normal control group, which 
was approximately restored to normal when administered 
with pumpkin powder and glibenclamide. High dose 
pumpkin (2 g/kg) consumption significantly increased the 
mean diameter of islets as compared to that of diabetic 
control group. With respect to the number of islets, 
significant difference was found between the group fed 
low dose pumpkin (1 g/kg) and the diabetic control group 
(Table 2 and Figure 1) (p < 0.05).  
 
 
DISCUSSION 
 
Results obtained in this study indicated that admini-
stration of pumpkin powder for 4 weeks in diabetic rats 
significantly reduced glucose, cholesterol, triglyceride, 
LDL and CRP levels as compared to diabetic control 
group. In addition, this plant was found to increase blood 
insulin and HDL levels, although this was not significant. 
Histological analysis showed significant difference in the 
mean diameter and the number of Langerhans islets 
between the diabetic control group and the normal control 
group. The mean diameter of islets in the diabetic group 
was significantly decreased as compared to that of the 
normal control group, which was consistent with other 
studies (Asgary et al., 2008; Mohajeri et al., 2009). It is 
evident from the results that the number and mean 
diameter of pancreatic islets increased in the group fed 
with pumpkin as compared to the diabetic group which 
illustrates the effects of pumpkin 
powder on repair and restoration of pancreatic tissue. 
Studies suggest that alloxan selectively destroys 
pancreatic β cells, therefore making it a suitable drug for 
induction of experimental diabetes. Its structural 
resemblance to glucose enables alloxan to enter β cells 
plasma membrane via glucose transporters (Glut2). Also, 
alloxan produces re-active oxygen species which is 
limited to the pancreatic islets (Elsner et al., 2006; 
Lenzen, 2008). As a result of the higher concentration of 
plasma, free radicals oxidative stress increases which is 
of particular importance in the pathogenesis of various 
diseases, including cardiovascular disease and diabetes 
(Potapovich and Kostyuk, 2003).  
Pumpkin contains various biologically active com-
ponents, such as polysaccharides, paraaminobenzoic 
acid, fixed oils, sterols, proteins, peptides, carotenoids, g-
aminobutyric acid and vitamins (Murkovic et al., 2002; 
Matus et al., 1993; Bombardelli and Morazzoni, 1997). 
The results of this study also  showed  that  pumpkin  has 
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Figure 1. Pancreatic islets in the normal control (A), diabetic control (B), diabetic rats 
treated with glibenclamide (C), diabetic rats treated with pumpkin powder (1 g/kg) (D) and 
diabetic rats treated with pumpkin powder (2 g/kg) (E) (40 ×). 
 
 
 
that pumpkin has antioxidant activity.  
Anti-oxidants are substances that protect cell mem-
branes and other components of an organism against 
damage caused by oxidants. These compounds function 
by collecting free radicals, transferring electron to them 
and ultimately rendering them inactive (Venkat et al., 
2006; Vaya and  Aviram,  2002). Antioxidant  compounds 
also increase the number of β pancreatic cells by enhan-
cing the repair and restoration of these cells. Numerous 
studies have shown that administration of antioxidants to 
diabetic rats significantly increases the number of β cells 
(Asgary et al., 2008). Studies have indicated that admini-
stration of quercetin to β cells in vitro, causes an increase 
in the number of these cells, which is due to  an  increase 
 
 
 
 
in DNA replication in pancreatic islet cells (Hii and 
Howell, 1984). Therefore, the pancreas protective effect 
of pumpkin and its hypoglycemic properties should be 
attributable, in part, to antioxidant activity of this fruit. 
Abdel-Hassan et al. (2000) found that saponin extracted 
from colocynth (Citrullus colocynthis), from the 
Cucurbitaceae, has high anti-diabetic activities. Flavonoid 
compounds, including quercetin with antioxidant activity 
also possess hypoglycaemic effect in diabetic rats 
(Rauter et al., 2010). Moreover, the presence of pectin 
itself can serve as a hypoglycaemic agent in pumpkin 
(Gourgue et al., 1992).  
Medicinal plants, such as Aloe vera L., Ocimum 
sanctum L. and Alpinia galanga (L.), which contain 
polysaccharides, have been shown to increase the levels 
of serum insulin, reduce blood glucose level or improve 
tolerance of glucose (Mukherjee et al., 2006). It has also 
been found that pumpkin polysaccharides could increase 
the superoxide dismutase and glutathione peroxidase 
activity and reduce the malonaldehyde in mice serum 
which shows an increase in antioxidant capacity (Xu, 
2000). The existence of high level of polysaccharides in 
the examined pumpkin in this study should therefore, be 
another reason for hypoglycemic activity of pumpkin. 
The lipid reducing effects of pumpkin is probably due to 
its fibres. These substances reduce plasma LDL levels by 
inhibiting the absorption of bile acids and cholesterol and 
enhancing the activity of LDL receptors. Furthermore, a 
fiber-rich diet reduces triglyceride levels by suppressing 
lipogenesis in the liver (Romero et al., 2002; Lecumberri 
et al., 2007). The presence of unsaturated fatty acids, 
such as oleic acid and linoleic acid in pumpkin seed 
reduce cholesterol levels in rats (Takada et al., 1994). 
The lipid-reducing properties of this plant are partly 
attributed to the pectin present in it. Previous data 
suggest that diets rich in pectin facilitate excretion of bile 
acids which lead to their synthesis increase from 
cholesterol in the liver and ultimately reduction of blood 
cholesterol levels (Fernandez et al., 1990). Pectin en-
hances the activity of lipoprotein lipase in fat tissue 
and heart, resulting in higher absorption of triglyceride 
rich lipoproteins (very low density lipoprotein (VLDL) and 
chylomicron) in tissues other than liver to promote their 
breakdown and therefore reducing triglyceride levels 
(Gomathy et al., 1989). Since cholesterol plays a crucial 
role in lipoprotein biosynthesis and LDL’s contain the 
highest level of cholesterol, LDL is likely to deplete follo-
wing a reduction in cholesterol levels. On the other hand, 
LDL reduction may be due to an increase in LDL cata-
bolism. By regulating LDL receptor gene, flavonoids 
increase the number of LDL receptors on the surface of 
liver cells. Following recognition and attachment of LDL 
apoprotein to LDL receptors, LDL is driven into the 
hepatocyte and removed from the blood stream (Pal et 
al., 2003). 
With respect to increase in CRP levels in rats our 
results were consistent with the  findings  of  Goyal  et  al.  
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(2008). No reports were found regarding the effects of 
pumpkin on CPR serum concentration in diabetic rats. It 
is speculated that the anti-inflammatory effects of this 
plant is related to its anti-oxidant compounds, such as 
flavonoids. It is also established that quercetin, from the 
class of falvonoids, provide protection against free 
radicals, chelate metal ion transporters and also inhibit 
oxidases including lipooxygenase (Lean et al., 1999). 
By considering all these facts, it can be concluded that 
pumpkin has potential antidiabetic properties, which may 
suggest the inclusion of this plant in antidiabetic regimens 
to treat human diabetes. However, further studies in 
detail are warranted to explore its active ingredients res-
ponsible for the beneficial action and the mechanisms 
involved. Controlled clinical trials are also strongly 
needed to confirm the hypoglycemic effects in human 
subjects. These are our focus for future studies. 
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